The global artificial vital organs and
medical bionics market is expected to reach USD 45.92 billion by
2022, according to a new report by Grand View Research Inc. Key growth drivers
identified in the artificial vital organs market include increasing base of
geriatric population suffering from chronic diseases such as cardiovascular and
respiratory diseases leading to organ failures or damage.
Furthermore,
the increasing number of patients suffering from physical disabilities such as
loss of limbs and arms owing to congenital factors, accidents, serving in armed
forces and industrial accidents is likely to positively reinforce medical
bionics market growth over the forecast period.
The
proliferation of universal health coverage schemes launched by various
governments and increasing public and private reimbursement policy coverage are
major trends expected to boost the usage rates of artificial vital organs and
medical bionics in the next seven years.
The
artificial vital organs market includes products such as artificial heart,
pancreas, kidneys, and lungs. These are used for organ transplantation in
patients suffering with organ damages or complete organ failures.
In 2014,
artificial kidney market accounted for the largest market share of over 60%
owing to increasing prevalence of high blood sugar, hypertension, post-surgery
infections, glomerular diseases, injury or burns, HIV, and other risk factors.
Artificial
liver is expected to be the fastest growing product segment growing at a
lucrative rate over the forecast period of seven years. Key factors attributing
to its rapid growth include increasing prevalence of chronic lung diseases such
as COPD and disadvantages of using mechanical ventilators.
The medical
bionics segment includes products such as brain, ear, vision bionics, exoskeleton,
and bionic limbs. In 2014, brain bionics held the largest market share of
nearly 41% due to the continually increasing number of patients suffering from
neurological conditions. Furthermore, non-invasive nature of spinal cord
stimulators, vagus nerve stimulators, and deep brain stimulators are key
factors positively impacting market growth in the next seven years.
Exoskeletons are likely to witness a rapid rise in demand owing to its wide
applications in rescue, emergency response, home healthcare, and patient
rehabilitation.
To request a
sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/artificial-vital-organs-and-medical-bionics-market
Further key findings from the study suggest:
- North America accounted for the largest market share of over 40% in 2014 owing to increasing prevalence of geriatric population suffering with organ damages or failures coupled with increasing numbers of physically challenged persons opting to use prosthetic limbs due to rising awareness and better reimbursement policies for such procedures
- Asia Pacific is expected to be the fastest growing market in the next seven-year period. Key factors contributing to growth in Asia Pacific are increase in public and private healthcare expenditure, penetration of healthcare insurance across urban and rural centers. Furthermore, increase in chronic diseases and increase in medical tourism are also expected to significantly boost the artificial vital organ transplant and medical bionics market over the forecast period.
- The global vital organ transplant and medical bionics market is dominated by players such as Abiomed, Touch Bionics, Baxter, Medtronics, Ottobock Healthcare, and Heartware.
See More
Reports of This Category:
About
Grand View Research:
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email:
sales@grandviewresearch.com
No comments:
Post a Comment